Pharmabiz

Andelyn and its curator platform achieve first US FDA-approved commercial gene therapy manufacturing milestone following US FDA’s approval of Ultragenyx’s Fayuvi to treat ...

Andelyn and its curator platform achieve first US FDA-approved commercial gene therapy manufacturing milestone following US FDA’s approval of Ultragenyx’s Fayuvi to treat Sanf ...
Pharmabiz

Sagility India enters Asia’s top 60 best workplaces, ranked 57 in 2026 by Great Place to Work

Sagility India enters Asia’s top 60 best workplaces, ranked 57 in 2026 by Great Place to Work: Our Bureau Bengaluru Monday, September 21, 2026, 17:45 Hrs [IST] Sagility India, a ...
Pharmabiz

Masters’ Union University launches Kalam School of Bioscience

Masters’ Union University launched the Kalam School of Bioscience, a new school focused on bringing together biology, technology, engineering, healthcare and entrepreneurship as advances in genomics, ...
Pharmabiz

One in four doctors nearing retirement age as WHO warns of global health workforce gap

One in four doctors nearing retirement age as WHO warns of global health workforce gap: Geneva Monday, September 21, 2026, 17:00 Hrs [IST] The World Health Organization (WHO) has ...
Pharmabiz

AstraZeneca & Daiichi Sankyo’s Enhertu recommended approval in EU as adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early ...

AstraZeneca & Daiichi Sankyo’s Enhertu recommended approval in EU as adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early br ...
Pharmabiz

Chugai obtains Japanese approval for FoundationOne CDx Cancer Genomic Profile as a companion diagnostic of lorlatinib for ALK fusion gene-positive NSCLC

Chugai obtains Japanese approval for FoundationOne CDx Cancer Genomic Profile as a companion diagnostic of lorlatinib for ALK fusion gene-positive NSCLC: Tokyo Monday, September 2 ...
Pharmabiz

Akums Drugs announces DCGI-approved triple therapy for H. pylori infection

Akums Drugs announces DCGI-approved triple therapy for H. pylori infection: Our Bureau, Mumbai Monday, September 21, 2026, 14:50 Hrs [IST] Akums Drugs & Pharmaceuticals Ltd., Indi ...
Opinion
PharmabizOpinion

India must build robust clinical ecosystems around emerging technologies: Dr Sudhir Srivastava

India must build robust clinical ecosystems around emerging technologies: Dr Sudhir Srivastava: Our Bureau, Mumbai Monday, September 21, 2026, 14:40 Hrs [IST] India is entering a ...
Pharmabiz

Robotic-assisted surgery in India enters its next phase as Intuitive introduces da Vinci 5

Robotic-assisted surgery in India enters its next phase as Intuitive introduces da Vinci 5: Our Bureau, Bengaluru Monday, September 21, 2026, 14:30 Hrs [IST] Intuitive, a global t ...
Pharmabiz

Ministry of Ayush advances AI for Ayurveda and traditional medicine

Ministry of Ayush advances AI for Ayurveda and traditional medicine: Our Bureau, Mumbai Monday, September 21, 2026, 14:15 Hrs [IST] Building on the digital foundation laid by Ayus ...
Pharmabiz

EMA committee recommends marketing approval for Novartis Cosentyx in polymyalgia rheumatica

EMA committee recommends marketing approval for Novartis Cosentyx in polymyalgia rheumatica: Basel Monday, September 21, 2026, 14:00 Hrs [IST] Novartis announced that the Committe ...
Pharmabiz

Integrated care emerges as the next frontier in cancer treatment as women’s cancer burden rises

Integrated care emerges as the next frontier in cancer treatment as women’s cancer burden rises: Our Bureau, Mumbai Monday, September 21, 2026, 13:50 Hrs [IST] As the burden of ...